Launch event of the RETHINKING Alzheimer’s disease White Paper

The launch event of the RETHINKING Alzheimer’s disease White Paper, calling for change in Alzheimer’s care, will take place virtually on 24 January 2023 from 12:00 – 13:30. The European Brain Council (EBC) in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA) will present its White Paper “RETHINKING Alzheimer’s disease: Detection and diagnosis“. This paper is the first of EBC’s “RETHINKING Alzheimer’s disease” project that is looking at how to improve the detection, diagnosis, care and monitoring of AD. The White Paper is particularly looking at how to detect and diagnose the disease at an earlier stage (at mild cognitive impairment stage) and what new care pathways would need to be implemented to reach out patients at that stage. With disease modifying treatments targeting patients with MCI that may come to the market in the near future, it is also important to see how the healthcare systems are prepared to provide these new treatments.